Both in Biotechnology
Candel Therapeutics vs Ginkgo Bioworks Holdings
Over the past year CADL returned +76.4% and DNA returned +0.5%; their daily moves had a correlation of 0.35.
CADL +76.4% DNA +0.5%Growth of $1, one year, split-adjusted
| Metric | CADL | DNA |
|---|---|---|
| Price | $9.05 | $11.65 |
| Market cap | $692.5M | $784.5M |
| Today | +2.61% | +8.27% |
| 1 month | −8.3% | −6.1% |
| 6 months | +18.6% | +15.6% |
| Year to date | +60.2% | +40.2% |
| 1 year | +73.4% | −8.9% |
| Revenue growth (YoY) | — | −48.5% |
| Gross margin | — | 91.5% |
| Net margin | — | −231.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 7.0× |
| Net cash | $153.7M | $302.2M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 128.9% |
| Short % of float | 21.5% | 18.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).